Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,706
Closed -$592K 238
2015
Q1
$592K Buy
+3,706
New +$584K 0.05% 92
2014
Q1
Sell
-2,668
Closed -$304K 175
2013
Q4
$304K Sell
2,668
-52,603
-95% -$5.98M 0.02% 254
2013
Q3
$6.19M Buy
55,271
+4,739
+9% +$514K 0.49% 34
2013
Q2
$4.99M Buy
+50,532
New +$5.24M 0.46% 34

Other funds holding AMGN

Maple Securities USA's AMGN Position: Q2 2015 in Review

Maple Securities USA sold out of Amgen (AMGN) in Q2 2015, closing a stake of 3,706 shares — an estimated $592K sold.

Maple Securities USA first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $6.19M in Q3 2013. 1,366 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Maple Securities USA reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
  • Maple Securities USA sold 3,706 Amgen shares in Q2 2015, an estimated $592K.
  • Maple Securities USA first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
  • Maple Securities USA's Amgen position peaked at $6.19M in Q3 2013.
  • 1,366 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.